VitaNova Life Sciences Corp Balance Sheet
VNOV|8 years of annual SEC 10-K data (FY2018-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 8 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Total Assets
$2M
FY2025
Cash
N/A
Cash and equivalents
Total Debt
N/A
FY2025
Shareholder Equity
$2M
FY2025
VitaNova Life Sciences Corp had $2M in total assets and $2M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Piotroski F-Score: 0/9 criteria passed
- Altman Z-Score 3.24 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | - | - | $8.7K | $23.1K | $0 | $0 | $0 | $4.4K |
| Accounts Receivable | $1.3M | $0 | - | - | - | - | - | - |
| Inventory | $44.2K | $132.9K | $0 | - | - | - | - | - |
| Current Assets | $2.3M | $1.2M | $8.7K | $23.1K | $0 | $0 | $0 | $4.4K |
| Total Assets | $2.3M | $1.2M | $8.7K | $23.1K | $0 | $0 | $0 | $47.8K |
| Current Liabilities | $347.6K | $136.9K | $67.9K | $58.1K | $174.7K | $122.6K | $50.2K | $0 |
| Shareholders' Equity | $1.9M | $1.1M | -$59.2K | -$35.0K | -$174.7K | -$122.6K | -$50.2K | $42.2K |